Individualized early goal-directed therapy in systemic Inflammation: is full utilization of preload reserve the optimal strategy?
Standard
Individualized early goal-directed therapy in systemic Inflammation: is full utilization of preload reserve the optimal strategy? / Wodack, Karin H; Poppe, Annika M; Tomkötter, Lena; Bachmann, Kai A; Strobel, Cilly M; Bonk, Sarah; Havel, Jan; Heckel, Kai; Gocht, Andreas; Saugel, Bernd; Mann, Oliver; Izbicki, Jakob R; Goetz, Alwin E; Trepte, Constantin J C; Reuter, Daniel A.
In: CRIT CARE MED, Vol. 42, No. 12, 01.12.2014, p. e741-51.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Individualized early goal-directed therapy in systemic Inflammation: is full utilization of preload reserve the optimal strategy?
AU - Wodack, Karin H
AU - Poppe, Annika M
AU - Tomkötter, Lena
AU - Bachmann, Kai A
AU - Strobel, Cilly M
AU - Bonk, Sarah
AU - Havel, Jan
AU - Heckel, Kai
AU - Gocht, Andreas
AU - Saugel, Bernd
AU - Mann, Oliver
AU - Izbicki, Jakob R
AU - Goetz, Alwin E
AU - Trepte, Constantin J C
AU - Reuter, Daniel A
PY - 2014/12/1
Y1 - 2014/12/1
N2 - OBJECTIVES: In severe acute pancreatitis, the administration of fluids in the presence of positive fluid responsiveness is associated with better outcome when compared to guiding therapy on central venous pressure. We compared the effects of such consequent maximization of stroke volume index with a regime using individual values of stroke volume index assessed prior to severe acute pancreatitis induction as therapeutic hemodynamic goals.DESIGN: Prospective, randomized animal study.SETTING: University animal research laboratory.SUBJECTS: Thirty domestic pigs.INTERVENTIONS: After randomization, fluid resuscitation was started 2 hours after severe acute pancreatitis induction and continued for 6 hours according to the respective treatment algorithms. In the control group, fluid therapy was directed by maximizing stroke volume index, and in the study group, stroke volume index assessed prior to severe acute pancreatitis served as primary hemodynamic goal.MEASUREMENTS AND MAIN RESULTS: Within the first 6 hours of severe acute pancreatitis, the study group received a total of 1,935.8 ± 540.7 mL of fluids compared with 3,462.8 ± 828.2 mL in the control group (p < 0.001). Pancreatic tissue oxygenation did not differ significantly between both groups. Vascular endothelial function, measured by flow-mediated vasodilation before and 6 hours after severe acute pancreatitis induction, revealed less impairment in the study group after treatment interval (-90.76% [study group] vs -130.89% [control group]; p = 0.046). Further, lower levels of heparan sulfate (3.41 ± 5.6 pg/mL [study group] vs 43.67 ± 46.61 pg/mL [control group]; p = 0.032) and interleukin 6 (32.18 ± 8.81 pg/mL [study group] vs 77.76 ± 56.86 pg/mL [control group]; p = 0.021) were found in the study group compared with control group. Histopathological examination of the pancreatic head and corpus at day 7 revealed less edema for the study group compared with the control group (1.82 ± 0.87 [study group] vs 2.89 ± 0.33 [control group, pancreatic head]; p = 0.03; 2.2 ± 0.92 [study group] vs 2.91 ± 0.3 [control group, pancreatic corpus]; p = 0.025).CONCLUSIONS: Individualized optimization of intravascular fluid status during the early course of severe acute pancreatitis, compared with a treatment strategy of maximizing stroke volume by fluid loading, leads to less vascular endothelial damage, pancreatic edema, and inflammatory response.
AB - OBJECTIVES: In severe acute pancreatitis, the administration of fluids in the presence of positive fluid responsiveness is associated with better outcome when compared to guiding therapy on central venous pressure. We compared the effects of such consequent maximization of stroke volume index with a regime using individual values of stroke volume index assessed prior to severe acute pancreatitis induction as therapeutic hemodynamic goals.DESIGN: Prospective, randomized animal study.SETTING: University animal research laboratory.SUBJECTS: Thirty domestic pigs.INTERVENTIONS: After randomization, fluid resuscitation was started 2 hours after severe acute pancreatitis induction and continued for 6 hours according to the respective treatment algorithms. In the control group, fluid therapy was directed by maximizing stroke volume index, and in the study group, stroke volume index assessed prior to severe acute pancreatitis served as primary hemodynamic goal.MEASUREMENTS AND MAIN RESULTS: Within the first 6 hours of severe acute pancreatitis, the study group received a total of 1,935.8 ± 540.7 mL of fluids compared with 3,462.8 ± 828.2 mL in the control group (p < 0.001). Pancreatic tissue oxygenation did not differ significantly between both groups. Vascular endothelial function, measured by flow-mediated vasodilation before and 6 hours after severe acute pancreatitis induction, revealed less impairment in the study group after treatment interval (-90.76% [study group] vs -130.89% [control group]; p = 0.046). Further, lower levels of heparan sulfate (3.41 ± 5.6 pg/mL [study group] vs 43.67 ± 46.61 pg/mL [control group]; p = 0.032) and interleukin 6 (32.18 ± 8.81 pg/mL [study group] vs 77.76 ± 56.86 pg/mL [control group]; p = 0.021) were found in the study group compared with control group. Histopathological examination of the pancreatic head and corpus at day 7 revealed less edema for the study group compared with the control group (1.82 ± 0.87 [study group] vs 2.89 ± 0.33 [control group, pancreatic head]; p = 0.03; 2.2 ± 0.92 [study group] vs 2.91 ± 0.3 [control group, pancreatic corpus]; p = 0.025).CONCLUSIONS: Individualized optimization of intravascular fluid status during the early course of severe acute pancreatitis, compared with a treatment strategy of maximizing stroke volume by fluid loading, leads to less vascular endothelial damage, pancreatic edema, and inflammatory response.
KW - Acute Disease
KW - Animals
KW - Disease Models, Animal
KW - Endothelium, Vascular
KW - Enzyme-Linked Immunosorbent Assay
KW - Fluid Therapy
KW - Glycocalyx
KW - Hemodynamics
KW - Heparitin Sulfate
KW - Inflammation
KW - Pancreatitis
KW - Prospective Studies
KW - Random Allocation
KW - Severity of Illness Index
KW - Stroke Volume
KW - Swine
KW - Syndecan-1
U2 - 10.1097/CCM.0000000000000657
DO - 10.1097/CCM.0000000000000657
M3 - SCORING: Journal article
C2 - 25402295
VL - 42
SP - e741-51
JO - CRIT CARE MED
JF - CRIT CARE MED
SN - 0090-3493
IS - 12
ER -